Search Results

There are 14592 results for: content related to: Impact of psychosocial status and disease knowledge on deferoxamine adherence among thalassaemia major adolescents

  1. You have free access to this content
    Desferrioxamine mesylate for managing transfusional iron overload in people with transfusion-dependent thalassaemia

    Intervention Review

    The Cochrane Library

    Sheila A Fisher, Susan J Brunskill, Carolyn Doree, Sarah Gooding, Onima Chowdhury and David J Roberts

    Published Online : 21 AUG 2013, DOI: 10.1002/14651858.CD004450.pub3

  2. Deferasirox for managing iron overload in people with thalassaemia

    Intervention Review

    The Cochrane Library

    Claudia Bollig, Lisa K Schell, Gerta Rücker, Roman Allert, Edith Motschall, Charlotte M Niemeyer, Dirk Bassler and Joerg J Meerpohl

    Published Online : 15 AUG 2017, DOI: 10.1002/14651858.CD007476.pub3

  3. You have free access to this content
    Deferasirox for managing transfusional iron overload in people with sickle cell disease

    Intervention Review

    The Cochrane Library

    Joerg J Meerpohl, Lisa K Schell, Gerta Rücker, Edith Motschall, Nigel Fleeman, Charlotte M Niemeyer and Dirk Bassler

    Published Online : 4 JUN 2014, DOI: 10.1002/14651858.CD007477.pub3

  4. You have free access to this content
    Translocation of iron from lysosomes into mitochondria is a key event during oxidative stress-induced hepatocellular injury

    Hepatology

    Volume 48, Issue 5, November 2008, Pages: 1644–1654, Akira Uchiyama, Jae-Sung Kim, Kazuyoshi Kon, Hartmut Jaeschke, Kenichi Ikejima, Sumio Watanabe and John J. Lemasters

    Version of Record online : 8 JUL 2008, DOI: 10.1002/hep.22498

  5. Opinion

    Seminars in Dialysis

    Volume 3, Issue 1, January 1990, Pages: 8–20,

    Version of Record online : 1 OCT 2007, DOI: 10.1111/j.1525-139X.1990.tb00004.x

  6. Consequences and costs of noncompliance with iron chelation therapy in patients with transfusion-dependent thalassemia: a literature review

    Transfusion

    Volume 47, Issue 10, October 2007, Pages: 1919–1929, Thomas E. Delea, John Edelsberg, Oleg Sofrygin, Simu K. Thomas, Jean-Francois Baladi, Pradyumna D. Phatak and Thomas D. Coates

    Version of Record online : 18 SEP 2007, DOI: 10.1111/j.1537-2995.2007.01416.x

  7. Use of Deferoxamine in the Treatment of Aluminum Overload in Dialysis Patients

    Seminars in Dialysis

    Volume 1, Issue 1, January 1988, Pages: 55–61, Kenneth Abreo

    Version of Record online : 16 SEP 2009, DOI: 10.1111/j.1525-139X.1988.tb00769.x

  8. Persistence and compliance of deferoxamine versus deferasirox in Medicaid patients with sickle-cell disease

    Journal of Clinical Pharmacy and Therapeutics

    Volume 37, Issue 2, April 2012, Pages: 173–181, L. B. Jordan, F. Vekeman, A. Sengupta, M. Corral, A. Guo and M. S. Duh

    Version of Record online : 18 MAY 2011, DOI: 10.1111/j.1365-2710.2011.01276.x

  9. You have free access to this content
    Chelation treatment in sickle-cell-anaemia: much ado about nothing?

    British Journal of Haematology

    Volume 154, Issue 5, September 2011, Pages: 545–555, Gaetano Lucania, Angela Vitrano, Aldo Filosa and Aurelio Maggio

    Version of Record online : 28 JUN 2011, DOI: 10.1111/j.1365-2141.2011.08769.x

  10. Reduction of body iron stores to normal range levels in thalassaemia by using a deferiprone/deferoxamine combination and their maintenance thereafter by deferiprone monotherapy

    European Journal of Haematology

    Volume 85, Issue 5, November 2010, Pages: 430–438, Annita Kolnagou, Marios Kleanthous and George J. Kontoghiorghes

    Version of Record online : 16 JUL 2010, DOI: 10.1111/j.1600-0609.2010.01499.x

  11. Solution equilibria of deferoxamine amides

    Journal of Pharmaceutical Sciences

    Volume 91, Issue 7, July 2002, Pages: 1733–1741, Peter M. Ihnat, Jonathan L. Vennerstrom and Dennis H. Robinson

    Version of Record online : 3 MAY 2002, DOI: 10.1002/jps.10168

  12. Synthesis and solution properties of deferoxamine amides

    Journal of Pharmaceutical Sciences

    Volume 89, Issue 12, December 2000, Pages: 1525–1536, Peter M. Ihnat, Jonathan L. Vennerstrom and Dennis H. Robinson

    Version of Record online : 17 OCT 2000, DOI: 10.1002/1520-6017(200012)89:12<1525::AID-JPS3>3.0.CO;2-T

  13. Compliance of deferoxamine injection in beta-thalassaemia major patients in Iran

    Transfusion Medicine

    Volume 22, Issue 2, April 2012, Pages: 104–107, M. Rashid and M. Karimi

    Version of Record online : 30 DEC 2011, DOI: 10.1111/j.1365-3148.2011.01130.x

  14. You have free access to this content
    Deferiprone versus deferoxamine in thalassemia intermedia: Results from a 5-year long-term Italian multicenter randomized clinical trial

    American Journal of Hematology

    Volume 90, Issue 7, July 2015, Pages: 634–638, Giuseppina Calvaruso, Angela Vitrano, Rosario Di Maggio, Eliana Lai, Grazia Colletta, Alessandra Quota, Calogera Gerardi, Luciana Concetta Rigoli, Massimiliano Sacco, Lorella Pitrolo and Aurelio Maggio

    Version of Record online : 3 MAY 2015, DOI: 10.1002/ajh.24024

  15. The effects of conjugated deferoxamine in porcine skin flaps

    Head & Neck

    Volume 22, Issue 6, September 2000, Pages: 579–584, David B. Hom, George S. Goding Jr., Julie A. Price, Kerri J. Pernell and Robert H. Maisel

    Version of Record online : 8 AUG 2000, DOI: 10.1002/1097-0347(200009)22:6<579::AID-HED6>3.0.CO;2-X

  16. You have free access to this content
    Synthesis of nano-niosomal deferoxamine and evaluation of its functional characteristics to apply as an iron-chelating agent

    The Canadian Journal of Chemical Engineering

    Volume 96, Issue 1, January 2018, Pages: 107–112, Adel Marzban, Azim Akbarzadeh, Mehdi Shafiee Ardestani, Fatemeh Ardestani and Mohsen Akbari

    Version of Record online : 21 NOV 2017, DOI: 10.1002/cjce.23048

  17. Deferoxamine promotes osteoblastic differentiation in human periodontal ligament cells via the nuclear factor erythroid 2-related factor-mediated antioxidant signaling pathway

    Journal of Periodontal Research

    Volume 49, Issue 5, October 2014, Pages: 563–573, J-H. Chung, Y-S. Kim, K. Noh, Y-M. Lee, S-W. Chang and E-C. Kim

    Version of Record online : 1 OCT 2013, DOI: 10.1111/jre.12136

  18. Pharmacological priming of adipose-derived stem cells for paracrine VEGF production with deferoxamine

    Journal of Tissue Engineering and Regenerative Medicine

    Volume 10, Issue 3, March 2016, Pages: E167–E176, Guei-Sheung Liu, Hitesh M. Peshavariya, Masayoshi Higuchi, Elsa C. Chan, Gregory J. Dusting and Fan Jiang

    Version of Record online : 30 JUL 2013, DOI: 10.1002/term.1796

  19. You have free access to this content
    Post-transcriptional regulation of plasminogen activator inhibitor-1 by intracellular iron in cultured human lung fibroblasts—interaction of an 81-kDa nuclear protein with the 3′-UTR

    Journal of Thrombosis and Haemostasis

    Volume 3, Issue 5, May 2005, Pages: 1001–1008, K. S. RADHA, M. SUGIKI, M. HARISH KUMAR, S. OMURA and M. MARUYAMA

    Version of Record online : 11 APR 2005, DOI: 10.1111/j.1538-7836.2005.01272.x

  20. You have full text access to this OnlineOpen article
    A randomised comparison of deferasirox versus deferoxamine for the treatment of transfusional iron overload in sickle cell disease

    British Journal of Haematology

    Volume 136, Issue 3, February 2007, Pages: 501–508, Elliott Vichinsky, Onyinye Onyekwere, John Porter, Paul Swerdlow, James Eckman, Peter Lane, Beatrice Files, Kathryn Hassell, Patrick Kelly, Felicia Wilson, Françoise Bernaudin, Gian Luca Forni, Iheanyi Okpala, Catherine Ressayre-Djaffer, Daniele Alberti, Jaymes Holland, Peter Marks, Ellen Fung, Roland Fischer, Brigitta U. Mueller, Thomas Coates and the Deferasirox in Sickle Cell Investigators

    Version of Record online : 21 DEC 2006, DOI: 10.1111/j.1365-2141.2006.06455.x